Fibrotic disorders associated with methysergide therapy for headache.
D000328:Adult; D000368:Aged; D001018:Aortic Diseases / Q000209:etiology; D001022:Aortic Valve Insufficiency / Q000209:etiology; D004878:Ergotamine / Q000009:adverse effects; D005260:Female; D006261:Headache / Q000188:drug therapy*; D006349:Heart Valve Diseases / Q000188:drug therapy; D006801:Humans; D006869:Hydronephrosis / Q000209:etiology; D008297:Male; D008784:Methysergide / Q000009:adverse effects*; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D011658:Pulmonary Fibrosis / Q000209:etiology; D012185:Retroperitoneal Fibrosis / Q000209:etiology / Q000473:pathology*; D012701:Serotonin / Q000378:metabolism; D013167:Spondylitis, Ankylosing / Q000150:complications; D014567:Urography
D012701:Serotonin; D004878:Ergotamine; D008784:Methysergide